Health TrialsbyHealthPanel

Unresectable Triple-negative Breast Cancer

1

Review clinical trials related to Unresectable Triple-negative Breast Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

TROPION Breast Respond in 1L TNBC

There are no real-world data available on the effectiveness and safety of Dato-DXd in adult patients with unresectable or metastatic triple-negative breast cancer who are not candidates for PD-1/PD-L1 inhibitor therapy. This NIS will investigate the effectiveness of Dato-DXd, the demographic and clinical characteristics of the patients, and treatment patterns.

Participants needed: 400
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyUpdated: Oct 9, 2026
Eligibility criteria

Age ≥18 years at the time of screening [+7]

Pregnancy or breastfeeding [+1]

Read more